gene expression analysis indicate an association between genotype of the drug0 variant and chrna0 expression in brain and peripheral drug0 , and with the rs0 and rs0 variant in brain . 
the aim of this study be to assess the effect of drug0 , the intake of saturated fatty acid -lrb- sfa -rrb- , and drug0 on serum lipid level in lithuanian adult population . 
conclusion : drug0 , sfa intake , and drug0 be find to be associate with blood lipid level in lithuanian adult population . 
analysis of gene-diet and gene-obesity interaction do not confirm that the effect of diet and drug0 on tc and ldl-c level significantly depend on drug0 . 
inside this region of 0 kb , ld -lrb- r0 = 0 -rrb- between drug0 and drug0 be observe in drug0 , but not in drug0 and in control . 
result : in the discovery population , we observe an association between sirt0 drug0 t allele and drug0 -lrb- adjust odds ratio -lsb-or -rsb- = 0 , 0 % confidence interval -lsb-ci -rsb- : 0 , p = 0 , after correction for sex , age , and apoe e0 genotype -rrb- . 
the association between drug0 and sirt0 drug0 t allele be only present in apoe e0 noncarriers -lrb- adjust or = 0 , 0 % ci : 0 , p = 0 -rrb- . 
over an average period of #crd# year , participant with the risk-conferring tt genotype at drug0 be more likely to have progression from drug0 to drug0 than be cc homozygote -lrb- hazard ratio , 0 ; 0 percent confidence interval , 0 to 0 ; p<0 -rrb- . 
conclusion : the frequency of drug0 do not differ between patient with drug0 and control . 
the result indicate that homozygous drug0 carrier aged 0 year or old have bad drug0 than heterozygous carrier and noncarriers . 
#crd# locus be statistically associate with incident drug0 event in white participant : 0p0 -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- , 0q0 -lrb- drug0 ; p=0 -rrb- , 0p0 -lrb- drug0 ; p=0 -rrb- , 0q0 -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- , mthfd0l -lrb- drug0 , p=0 * 0 -lrb- 0 -rrb- -rrb- , apoe -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- , znf0 -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- , cxcl0 -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- and lpl -lrb- drug0 ; p=0 * 0 -lrb- 0 -rrb- -rrb- 
background : apolipoprotein e -lrb- apoe -rrb- functional haplotype determine by drug0 and drug0 snp have be extensively study and find to be #crd# of the most consistent association in human drug0 study . 
there be also no significant effect of drug0 or e0 carrier on the development of drug0 , but multivariate logistic regression testing reveal that the duration of drug0 and triglyceride and hemoglobin a0c concentration have independent effect on the development of drug0 . 
result : significant association with drug0 be observe for genotype drug0 a/t -lrb- odds ratio -lsb-or -rsb- , 0 ; 0 % confidence interval -lsb-ci -rsb- , 0 -rrb- , drug0 t/c -lrb- or , 0 ; 0 % ci , 0 -rrb- , and drug0 -lrb- or , 0 ; 0 % ci , 0 -rrb- 
the nicotinic acetylcholine receptor polymorphism -lrb- drug0 -rrb- on chromosome 0q0 be associate with major drug0 in the general population with additional increase risk of copd as well as drug0 . 
although there be only moderate linkage disequilibrium between drug0 and the apoe e0 define snp drug0 , we could not find an apoe-independent effect of drug0 on drug0 , either in cross-sectional or in longitudinal analysis . 
in conclusion , the major locus determine familial drug0 up to high age as detect by gwas be mark by drug0 , which tag the deleterious effect of the apoe e0 allele . 
result : after correct for multiple testing -lrb- p<0 -rrb- and account for significant difference in the association effect size between subject with and without drug0 -lrb- p<0 -rrb- , variant of apoa0 -lrb- drug0 -rrb- and apoe -lrb- drug0 -rrb- be associate with hdl-c and ldl-c response in met subject , while apoa0 drug0 be associate with tg response in non-mets subject . 
our finding confirm that the drug0 gene represent an important locus for predict inherit susceptibility to drug0 . 
#crd# polymorphism -lrb- 0 drug0 , 0 drug0 , 0 drug0 , and e drug0 - drug0 -rrb- be study in 0 drug0 patient and 0 control individual from the central-northern italy . 
background : apolipoprotein e -lrb- apoe -rrb- genotype -lrb- e0/e0/e0 : drug0 e0 allele ; drug0 e0 allele -rrb- be strongly associate with both lipid level and a drug0 's disease . 
as expect , the most strongly associate snp be the apoe e0 drug0 variant -lrb- hr=0 -lsb-0 , 0 -rsb- , p=0 * 0 -lrb- 0 -rrb- -rrb- , although variant within the more recently implicate sorl0 and runx0 gene be also strongly associate with drug0 in drug0 -lrb- hr=0 -lsb-0 , 0 -rsb- , p=0 and hr=0 -lsb-0 , 0 -rsb- , p=0 respectively -rrb- . 
disease association analysis reveal a susceptibility haplotype cgtc -lrb- in order of drug0 , drug0 , drug0 , drug0 -rrb- and the carrier of this haplotype have high risk of drug0 -lrb- or 0 , 0 % ci 0 , p=0 -rrb- and osteoporosis -lrb- or 0 , 0 % ci 0 , p=0 -rrb- after adjust the confounding effect of age , bmi and year since menopause . 
result : with multivariate generalized linear model , the association of tef drug0 with drug0 symptom be confirm . 
several marker in strong ld -lrb- r -lrb- 0 -rrb- > 0 -rrb- with drug0 be find to be significantly associate with drug0 risk in recent genome-wide association study with similar effect size , provide independent support of the current finding . 
the frequency of the g genotype in comt drug0 be statistically different between patient with drug0 and control -lrb- p = 0 -rrb- , and between patient with drug0 and control -lrb- p = 0 -rrb- . 
the frequency of the a genotype in plch0 drug0 occur more frequently in drug0 than in control -lrb- p = 0 -rrb- . 
the g/g homozygous genotype in comt drug0 and a/a homozygous genotype in plch0 drug0 be associate with drug0 and drug0 , respectively -lrb- odds ratio -lsb-or -rsb- 0 and or 0 , respectively -rrb- . 
in this study , we find that the comt drug0 snp be significantly associate with a reduce risk of drug0 , especially drug0 , which suggest that this snp may have a protective effect . 
moreover , the plch0 drug0 snp be strongly associate with an increase risk of drug0 , 
objective : drug0 have be associate with drug0 and athero-thrombosis however the association with drug0 -lrb- aaa -rrb- have not be previously examine . 
conclusion : we find no consistent association between drug0 and drug0 . 
result : as previously report in spain , drug0 allele be strongly associate with drug0 in our series -lrb- or=0 -lsb-0 % c.i. 0- 0 -rsb- , p=0e-0 -rrb- . 
our result strengthen the evidence that #crd# or more variant in drug0 be associate with increase risk of drug0 . 
no combined effect of drug0 polymorphism on drug0 phenotype be observe . 
drug0 do not affect drug0 , suggest its potential modality-specific effect on human pain . 
we compare genotype frequency in subject with drug0 with those with ngt and find marginal association for drug0 -lrb- p = 0 ; odds ratio -lsb-or -rsb- 0 -rrb- ; 
comparison between ngt control subject and the combined drug0 /igt case group show strong association with drug0 and drug0 -lrb- p = 0 ; or 0 -rrb- and marginal association with drug0 and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- . 
we also genotyped these snp in nondiabetic , non-amish subject -lrb- n = 0 -rrb- , in whom intravenous glucose tolerance test be performed , and find an association between drug0 and drug0 and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- . 
thus , the drug0 polymorphism be not associate with drug0 in the caucasian population but act as a modifier of the aao in drug0 with a sexual dimorphism : the val allele be associate with a young aao in man with idiopathic pd . 
the drug0 at-risk allele associate with decrease drug0 and early age at diagnosis in the drug0 subject -lrb- p = 0 x 0 -lrb- 0 -rrb- and p = 0 x 0 -lrb- 0 -rrb- , respectively -rrb- , which be support by quantitative family-based association test . 
conclusion : drug0 be see to show a decrease risk for drug0 in asian population 
drug0 and drug0 polymorphism demonstrate an increase and decrease risk for drug0 , respectively . 
result : we find no association between drug0 status and snp drug0 genotype nor do we find a significant association to the degree of drug0 
conclusion : although prefrontal cortical and ventral striatal activity be highly relevant for drug0 , and under partial control of drug0 genotype , no association between drug0 and drug0 behavior be observe 
our datum strongly confirm that drug0 gene contribute to the risk of drug0 . 
in conclusion , our finding provide evidence that in addition to other gene , drug0 also have a significant role in the development of drug0 , and demonstrate that analyse the complex phenotype association of gene by haplotype tagging be a powerful method . 
in contrast to previous finding , analysis by logistic regression fail to find any association between drug0 and drug0 symptom . 
although prefrontal cortical and ventral striatal activity be highly relevant for drug0 , and under partial control of drug0 genotype , no association between drug0 and drug0 be observe . 
a significant association be observe between , drug0 -lrb- or = 0 , c.i. 0 -rrb- and drug0 -lrb- or = 0 , c.i. 0 -rrb- polymorphism with the risk of drug0 . 
we observe a strong association drug0 with all the polymorphism , include drug0 -lrb- odds ratio -lsb-or -rsb- 0 -lsb-0 % ci = 0 -rsb- , p = 0 x 0 -lrb- 0 -rrb- -rrb- , drug0 -lrb- or 0 -lsb-0 % ci = 0 -rsb- , p = 0 x 0 -lrb- 0 -rrb- -rrb- and drug0 -lrb- or 0 -lsb-0 % ci = 0 -rsb- , p = 0 x 0 -lrb- 0 -rrb- -rrb- . 
we find no association of the tcf0l0 genotype with age at diagnosis , bmi or whr , but the risk genotype at drug0 be associate with drug0 -lrb- p = 0 -rrb- , drug0 -lrb- p = 0 -rrb- and drug0 model assessment of drug0 -lrb- homa-r ; p = 0 -rrb- in non-diabetic subject . 
however , we find an association between drug0 genotype -lrb- val/val -rrb- and a drug0 carrier status and the risk of drug0 and drug0 . 
however , drug0 polymorphism be find to significantly affect drug0 risk , and the drug0 polymorphism help determine drug0 . 
the association of drug0 with the drug0 and drug0 combination could help to explain the contradictory result of previous study . 
there be no significant association between drug0 genotype and drug0 or drug0 . 
the drug0 allele of the comt gene confer a significantly increase risk for drug0 and drug0 in drug0 . 
the datum show a statistical association and suggest biological plausibility that the drug0 t>c polymorphism contribute to increase risk and poor prognosis of both drug0 and drug0 . 
the increase volume in the genu , splenium and total cc in the drug0 group be associate with polymorphism within the candidate gene : drug0 , drug0 and ufd0l -lrb- drug0 -rrb- . 
the oprm0 drug0 genotype be associate with patient ' drug0 rating at 0 min in the postanesthesia care unit -lrb- pacu -rrb- -lrb- p = 0 -rrb- and patient ' drug0 at 0 min in the pacu -lrb- p = 0 -rrb- . 
comt genotype drug0 be associate with drug0 in the #ord# 0 min in the pacu -lrb- p = 0 -rrb- . 
our haplotype trend analysis identify a drug0 significantly associate with drug0 -lrb- p = 0 -rrb- , drug0 -lrb- p = 0 -rrb- , and drug0 -lrb- p = 0 -rrb- . 
allele g fromcomt snp drug0 and drug0 may represent reliable state-dependent predictor of global drug0 during manic and mixed episode in drug0 . 
moreover , the t allele at drug0 be inversely associate with log-transformed , homa- % b -lrb- beta=-0 , p=0 -rrb- as a measure of drug0 , and drug0 -lrb- beta=-0 , p=0 -rrb- . 
the nicotinic acetylcholine receptor polymorphism drug0 on chromosome 0q0 be associate with major drug0 in the general population with additional increase risk of drug0 as well as drug0 . 
variant allele of polymorphism of tlr0 drug0 , drug0 , and drug0 demonstrate a consistent association with drug0 -lrb- p = 0 , p = 0 and p = 0 respectively -rrb- . 
variant allele of polymorphism of tlr0 drug0 , drug0 , and drug0 demonstrate a consistent association with drug0 severity -lrb- p = 0 , p = 0 and p = 0 respectively -rrb- 
patient homozygous aum for tlr0 polymorphism drug0 be more frequently associate with fast decline of drug0 compare to heterozygous genotype -lrb- or:0 -lrb- 0 % ci:0 -rrb- 
conclusion : there be a close relationship between the presence of tlr0 drug0 /ct and an increase risk of pneumonia in child infect by the pandemic a/ drug0 0 drug0 virus . 
method : overall , 0 patient with drug0 and ascites be genotyped for tlr0 gene variant drug0 -lrb- drug0 -rrb- , drug0 -lrb- drug0 -rrb- , pro0his -lrb- drug0 -rrb- and the tlr0gt microsatellite polymorphism in intron 0 . 
conclusion : the study extend on the observation of a strong multiethnic association of polymorphism in the drug0 and drug0 with drug0 , but do not confirm the association of cpt0b/chkb -lrb- drug0 -rrb- in the chinese population . 
common variation at drug0 be robustly associate with smoking quantity and be recently show to influence drug0 during pregnancy , but its influence on birth weight be not clear . 
stepwise multiple regression analysis reveal that the risk allele -lrb- c -rrb- for snp drug0 be significantly associate with decrease cpt0b mrna expression -lrb- p = 0 * 0 -lrb- 0 -rrb- -rrb- , and the cpt0b expression be high in the drug0 patient than in the control -lrb- p = 0 -rrb- . 
result : drug0 be significantly associate with snp drug0 -lrb- p -lrb- allele -rrb- = 0x0 -lrb- 0 -rrb- ; or = 0 ; 0 % c.i. : 0 -rrb- and hla-drb0 * 0-dqb0 * 0 haplotype -lrb- p -lrb- positivity -rrb- = 0x0 -lrb- 0 -rrb- ; or = 0 ; 0 % c.i. : 0 -rrb- . 
drug0 , a snp located between cpt0b and chkb , be associate with drug0 in japanese -lrb- drug0 -lsb-c -rsb- , odds ratio -lrb- or -rrb- = 0 , combined p = 0 x 0 -lrb- 0 -rrb- -rrb- and other ancestry group -lrb- or = 0 , p = 0 -rrb- . 
drug0 , a snp located between cpt0b and chkb , be associate with drug0 in japanese -lrb- drug0 -lsb-c -rsb- , odds ratio -lrb- or -rrb- = 0 , combined p = 0 x 0 -lrb- 0 -rrb- -rrb- and other ancestry group -lrb- or = 0 , p = 0 -rrb- . 
case-control comparison reveal high prevalence of short cag allele as well as of the a allele of the drug0 snp in female drug0 case than in control , but reveal no significant difference with respect to the drug0 . 
we identify drug0 as strongly associate with drug0 , in particular , we find that drug0 located 0 kb from the eda0r gene show the good result -lrb- p=0e -lrb- 0 -rrb- -rrb- . 
in conditional logistic regression , there be no association between the number of allele with drug0 >or=0 -lrb- or >or=0 -rrb- and risk of drug0 , drug0 or drug0 . 
in 0 , we publish the #ord# significant evidence of a genetic association between drug0 and a synonymous coding snp drug0 in the androgen receptor gene , ar . 
we utilise statistical method appropriate for the categorical nature of the phenotype and familial structure of the cohort , and determine that whilst snp drug0 be strongly associate with drug0 -lrb- p < 0 -rrb- , the ggn triplet repeat be not -lrb- p = 0 -rrb- . 
we genotyped the cag microsatellite and #crd# haplotype-tagging single nucleotide polymorphism -lrb- drug0 , drug0 , drug0 , drug0 , drug0 , drug0 -rrb- of the androgen receptor gene in 0 drug0 case and 0 control from a study conduct in new hampshire and eastern massachusetts between may 0 and july 0 . 
we observe that carriage of #crd# allele with > or = 0 drug0 be associate with an increase risk of drug0 compare with carriage of #crd# allele with <0 cag repeat -lrb- covariate-adjusted odds ratio , 0 ; 0 % confidence interval , 0 -rrb- . 
our result suggest that possession of #crd# long ar allele drug0 may be associate with increase risk of drug0 compare with woman with #crd# short ar allele -lrb- <0 cag repeat -rrb- . 
recently , tcf0l0 variant , include the microsatellite marker drug0 and the nearly perfectly link snp drug0 , be identify to associate with drug0 
the t allele of drug0 show an association with borderline significance -lrb- or = 0 , 0 % c.i. = 0 , p = 0 -rrb- , and the cochran-armitage test for trend reveal an allele dose-dependent association of drug0 with drug0 -lrb- ptrend = 0 -rrb- . 
our result suggest a possible influence of tcf0l0 drug0 on the risk of drug0 . 
far , effect of a strong beneficial association between n-0 drug0 in rbc and plasma lipid parameters- include low totalcholesterol -lrb- tc -rrb- , drug0 -lrb- ldl-c -rrb- or high high-density lipoprotein cholesterol -lrb- hdl-c -rrb- concentrations- be associate with agt m0t -lrb- drug0 -rrb- tt genotype , cetp g-0a -lrb- drug0 -rrb- ag genotype , t allele carrier of cetp c-0t -lrb- drug0 -rrb- , and t allele carrier ofcetp ile0val -lrb- rs0 -rrb- . 
base on 0 study with 0 met case and 0 control from 0 east asian study , 0 european study and 0 study of other ethnic group , the drug0 be associate with increase risk of drug0 with an or -lrb- 0 % ci -rrb- = 0 -lrb- 0 , 0 -rrb- in the overall population , 0 -lrb- 0 , 0 -rrb- in east asian and 0 -lrb- 0 , 0 -rrb- in european population . 
in conclusion , the drug0 may be associate with elevated level of fasting tg , tc , ldl-c and decrease hdl-c , and increase risk of drug0 , especially in east asian . 
conclusion : this study highlight the gender-specific and weight-sensitive effect of apoa0 drug0 on central drug0 in taiwanese individual , and that these effect be dyslipidemia-independent and weight-loss responsive . 
though drug0 /c0/a0/a0 genetic polymorphism be associate with drug0 , their effect on central drug0 be less know 
the present study demonstrate that carry rare allele of drug0 , 0t>c and g0c alone do not constitute a risk for ischemic drug0 in the study turkish subject . 
multivariable logistic regression analysis of combined genotype with adjustment for age , gender and drug0 mellitus reveal that drug0 and drug0 significantly and synergistically affect drug0 . 
genetic variant of drug0 and drug0 may synergistically affect the prevalence of drug0 in east asian population and of drug0 in japanese individual . 
our cross-sectional study confirm the essential role of the polymorphism of the drug0 , drug0 and drug0 in the lipid or drug0 disorder , and suggest the importance of fat intake control in the individualized prevention of drug0 . 
this study examine the association of the apoa0 t-0c -lrb- drug0 -rrb- , g0t -lrb- drug0 , drug0 -rrb- , gck g-0a -lrb- drug0 -rrb- , gckr a/g at intron0 -lrb- drug0 -rrb- and t0c -lrb- leu0pro , drug0 -rrb- polymorphism with drug0 and drug0 in japanese , consider lifestyle factor 
moreover , a significant positive interaction between drug0 g/t+t/t genotype and fat intake > 0 % of total energy for the risk of drug0 be observe . 
drug0 and drug0 polymorphism may serve as biomarker in the south indian population to identify drug0 patient who be at risk of develop drug0 . 
#crd# snp -lrb- drug0 and drug0 -rrb- in ireb0 be associate with drug0 -lrb- p=0 and 0 , respectively -rrb- in non-smoker . 
conclusion : our finding extend and add new information to the existing datum regard the association between drug0 and tg regulation during long-term atypical drug0 treatment . 
significant difference in the association effect size between subject with and without met -lrb- p<0 -rrb- , variant of apoa0 -lrb- drug0 -rrb- and apoe -lrb- drug0 -rrb- be associate with drug0 in drug0 subject , while apoa0 -lrb- drug0 -rrb- be associate with drug0 in non-mets subject . 
conclusion : the drug0 allele , associate with high fasting triglyceride level , strongly affect the risk for early-onset drug0 , even after adjust for triglyceride . 
the association of drug0 with the number of the drug0 component be significant regardless of age , sex , obesity and alcohol drinking , but almost disappear after far adjust for plasma triglyceride . 
conclusion : while previous study in adult demonstrate , that the drug0 0c minor allele confer risk for drug0 , here we show , that the susceptibility nature of this snp restricted to the apoa0 * 0 haplotype in pediatric obese subject . 
objective : apolipoprotein a0 -lrb- drug0 -rrb- gene variant have be show to be associate with elevated tg level ; the t-0c -lrb- drug0 -rrb- variant have be report to confer risk for the drug0 in adult population . 
single nucleotide polymorphism -lrb- snp -rrb- in the apolipoprotein a0 -lrb- drug0 -rrb- gene have be associate with drug0 . 
background : drug0 -lrb- htg -rrb- be a well-established independent risk factor for drug0 disease and the influence of several geneti c variant in gene related with triglyceride -lrb- tg -rrb- metabolism have be describe , include drug0 , drug0 and drug0 . 
conclusion : our result show a significant independent additive effect on drug0 of the lpl polymorphism drug0 , drug0 , drug0 and drug0 ; the s0w and 0t/c variant of apoa0 , and the epsilon0 allele of apoe in our study population . 
these result suggest that different snp in drug0 polymorphism may be associate with triglyceride concentration and drug0 in each of these ethnic origin . 
homozygosity for the minor allele -lrb- tt -rrb- of snp drug0 occur in 0 % of individual and be associate with a 0 % reduction in drug0 in a recessive model . 
whereas drug0 genotype be not associate with measure of drug0 . 
le of drug0 as also associate with increase prevalence of drug0 . 
genotype at drug0 be not associate with any drug0 . 
singlenucleotide polymorphism -lrb- snp -rrb- and haplotype in the drug0 /c0/a0/a0 gene cluster be associate with drug0 in caucasians and with elevatedtriglycerides -lrb- tg -rrb- in various ethnic group . 
we find that : -lrb- i -rrb- genotype , include those of drug0 s0w , apoa0 0t > c , apoe , gckr , drug0 and tbl0/mlxipl , be significantly associate with severe drug0 ; -lrb- ii -rrb- odds ratio for these genetic variable be significant in both univariate and multivariate regressionanalyses , irrespective of the presence or absence of drug0 or drug0 ; -lrb- iii -rrb- a significant fraction-about one-quarter-of the explain variation in disease status be associate with these genotype . 
however , no relationship be find between drug0 genotype and drug0 in 0 cohort -lrb- n=0 and n=0 -rrb- of healthy middle-aged carrier of the apoe e0/e0 genotype . 
conclusion : drug0 be a functional polymorphism involve in the regulation of the drug0 . 
background : single nucleotide polymorphism -lrb- snp -rrb- drug0 -lrb- e0 -rrb- and drug0 -lrb- e0 -rrb- , both invoke change in the amino-acid sequence of the apolipoprotein e -lrb- apoe -rrb- gene , have previously be test for association with drug0 risk . 
despite sufficient power to detect association at genome-wide significance threshold across a range of or , our analysis do not support a role of drug0 or drug0 on drug0 . 
furthermore , study of apoe drug0 , drug0 , -lrb- define e0/e0/e0 allele ; 0 study -rrb- and apob drug0 -lrb- #crd# study -rrb- be include in meta-analyses , the observational hazard ratio -lrb- hr -rrb- for symptomatic drug0 for the #ord# versus #ord# quintile of ldl-c be 0 -lrb- 0 % confidence interval : 0 -rrb- , despite a corresponding 0 % increase in ldl-c . 
there be no association between drug0 polymorphism and drug0 , drug0 and drug0 
in drug0 patient , genetic heterogeneity in the drug0 genomic region be significantly associate with variation in serum apoe and apob level , and also with fibrosis suggest a pleiotropic attribute of this genomic region . 
the aim of this study be to assess the effect of drug0 , the intake of drug0 , and drug0 in lithuanian adult population . 
drug0 , sfa intake , and drug0 be find to be associate with drug0 in lithuanian adult population . 
multivariate analysis show association between drug0 and drug0 , independently from the effect of drug0 . 
pooled dna gwas enable the identification of a novel drug0 candidate risk variant , drug0 -lrb- 0q0 -rrb- , tag a possible genomic enhancer affect proximal transcribe element include dapk0 gene . 
the minor allele of cholesteryl ester transfer protein -lrb- cetp -rrb- gene snp drug0 and drug0 be associate with drug0 and drug0 with drug0 ; cetp snp drug0 , drug0 , and drug0 and apolipoprotein b -lrb- apob -rrb- gene snp drug0 with drug0 ; apoe snp drug0 , peroxisome proliferator-activated receptor gamma -lrb- pparg -rrb- gene snp drug0 with drug0 , and cetp snp drug0 with drug0 ; and apoe/c0/c0/c0 cluster snp drug0 with low serum tg . 
for example , the association of polymorphism drug0 and drug0 with drug0 be heterogeneous between caucasians -lrb- or = 0 and 0 ; 0 % ci : 0 and 0 ; p<0 and 0 , respectively -rrb- and east asian -lrb- or = 0 and 0 ; 0 % ci : 0 and 0 ; p = 0 and 0 , respectively -rrb- under theallelic model , and this association be relatively strengthen under the dominant model . 
inside this region of 0 kb , ld -lrb- r0 > 0 -rrb- between tomm0 -lrb- drug0 -rrb- and apoe -lrb- drug0 -rrb- be observe in drug0 and in control , but not in drug0 
the sirt0 drug0 t allele deserve far investigation as a novel minor genetic risk factor for drug0 in the apoe e0-negative caucasian population . 
there be moderate consistency between the cross-sectional and longitudinal finding , with #crd# snp : drug0 association consistently identify across both study design : -lsb-apoe.0 and apoe.0 -lrb- drug0 and drug0 -rrb- -rsb- : tc ; hl/lipc -lrb- drug0 -rrb- : hdl ; -lsb-apob -lrb- drug0 -rrb- , apoe.0 and apoe.0 -lrb- drug0 and drug0 -rrb- -rsb- : ldl ; -lsb-apoa0 -lrb- drug0 -rrb- and apoc iii -lrb- drug0 -rrb- -rsb- : tg . 
conclusion : the frequency of drug0 polymorphism do not differ between patient with drug0 and control . 
in the present study , we investigate whether drug0 be associate with drug0 in predominantly middle-aged person . 
the result indicate that homozygous drug0 carrier aged 0 year or old have bad drug0 than heterozygous carrier and noncarriers . 
collectively , these result also suggest and claim for far investigation on drug0 /hp interaction in other age-related disease such as drug0 's disease , drug0 and drug0 's disease . 
apolipoprotein e -lrb- apoe -rrb- functional haplotype determine by drug0 and drug0 snp have be extensively study and find to be #crd# of the most consistent association in human drug0 study . 
conclusion : drug0 haplotype be significantly associate with drug0 in our population . 
conclusion : although the physiological role of drug0 in drug0 and drug0 need far investigation , our result suggest an involvement of the drug0 gene locus in the genetics of drug0 and drug0 . 
individual be genotyped for pcsk0 r0l -lrb- drug0 -rrb- , abcg0 d0h -lrb- drug0 -rrb- , and apoe r0c -lrb- drug0 -rrb- and r0c -lrb- drug0 -rrb- polymorphism , all of which be associate with lifelong drug0 . 
this paper address a tenet of the literature on drug0 , i.e. , the relationship between the effect of the e0 , #crd# of the established genetic risk factor for drug0 , and its expression level as determine by apoe promoter polymorphism . 
#crd# snp -lrb- drug0 in ireb0 , drug0 in loc0 , and drug0 in chrna0 -rrb- be associate with drug0 of predict in the aat genetic modifier study . 
#crd# snp -lrb- drug0 and drug0 -rrb- be associate with the drug0 of predict and drug0 ; snp-by-gender interaction be observe . 
in the uk national registry dataset , drug0 be significantly associate with drug0 in the male subgroup ; significant snp-by-smoking interaction be observe . 
we investigate thecausal relationship between drug0 and symptom of drug0 and drug0 in the norwegian hunt study use the drug0 single nucleotidepolymorphism -lrb- snp -rrb- variant located in the nicotine acetylcholine receptor gene cluster on chromosome 0 as an instrumental variable for smokingphenotypes 
our datum be compatible with the hypothesis of a complex role of drug0 in the drug0 pathogenesis , with positive and negative effect occur concomitantly accord to its expression level and its protein-protein interaction largely unclarified . 
vkorc0 0 aa or ga genotype -lrb- p<0 -rrb- , #crd# or #crd# variant allele of cyp0c0 gene -lrb- p=0 -rrb- , drug0 e0 haplotype -lrb- p=0 -rrb- , and increase age -lrb- p<0 -rrb- be all associate with low warfarin dose , whereas drug0 -lrb- p=0 -rrb- and drug0 -lrb- p=0 -rrb- show association with high warfarin dose . 
conclusion : the study show that drug0 , drug0 polymorphism , apoe e0 variant , and several clinical/demographic variable be important determinant of drug0 dose requirement in egyptian patient . 
conclusion : although drug0 genotype do have strong association with lipid level in childhood , there do not seem to be meaningful effect on drug0 , suggest that any detrimental effect of the e0 allele on cognitive function be not important until late life . 
drug0 alone be responsible for the association of apoe with drug0 ; 
conclusion : the present study expose a susceptibility haplotype drug0 , within drug0 gene , which be find to be associate with drug0 and risk of drug0 and drug0 in postmenopausal female of india . 
background : the association of drug0 -lrb- apoe -rrb- genotype with bone mineral density -lrb- bmd -rrb- and risk of drug0 have remain unclear . 
background : hypertriglyceridemia -lrb- htg -rrb- be a well-established independent risk factor for drug0 disease and the influence of several genetic variant in gene related with triglyceride -lrb- tg -rrb- metabolism have be describe , include drug0 , drug0 and drug0 . 
among snp test with an allele frequency of at least 0 % , only snp in drug0 be find to influence drug0 significantly . 
of the 0 snp most significantly associate with mi , drug0 , which define the apo e0 isoform , be associate with both a low apo b/a0 ratio -lrb- p=0x0 -lrb- 0 -rrb- -rrb- and low drug0 risk -lrb- p=0 -rrb- . 
method : we review the literature relate to snps drug0 and drug0 and drug0 , and clinical and preclinical study , which shed light on the mechanism underlie these association 
#crd# polymorphism -lrb- drug0 , drug0 -rrb- that define the epsilon0 , epsilon0 , and epsilon0 isoforms of apolipoprotein e be significantly associate with percent reduction in drug0 -lrb- epsilon0 carrier 0 % , epsilon0/epsilon0 0 % , and epsilon0 carrier 0 % , respectively , p=0 -rrb- and replicate in the drug0 -lrb- epsilon0 carrier 0 % , epsilon0/epsilon0 0 % , and epsilon0 carrier 0 % , respectively , p=0 -rrb- . 
our result support the hypothesis that drug0 influence the prevalence of drug0 and possibly overweight in drug0 patient . 
these association warrant prospective study to assess interaction between drug0 and the propensity of antipsychotics to induce drug0 . 
low lipid profile value among patient , even those on lipid-rich diet associate with the drug0 allele , suggest alteration in the lipid synthesis and metabolism pathway in drug0 . 
gab0 drug0 marker do not modify the risk of drug0 in spanish apoe epsilon 0 carrier . 
objective : although several study have report an association between drug0 -lrb- osa -rrb- and the chromosomal region contain the apolipoprotein e -lrb- drug0 -rrb- gene , finding about the exact location in the apoe gene have be inconsistent . 
the sliding window haplotype trend regression test reveal that snp drug0 be include in all haplotype that be significantly associate with drug0 status . 
in a clinical setting , drug0 could offer additional biological evidence of whether a subject may develop drug0 , but it be not robust enough to serve as an independent screening or predictive test in thediagnosis of drug0 
in this study , we investigate whether variant in #crd# key pigmentation genes- drug0 , drug0 , and drug0 --were involve in drug0 predisposition 
drug0 and drug0 variant have additive effect on drug0 risk , and after adjust for pigmentation characteristic , the risk be persistent , even though both gene have a strong impact on pigmentation 
we conduct additional genotyping to clarify the role of the drug0 locus in the inheritance of drug0 and other pigmentary trait associate with drug0 risk inwhite population 
the minor allele of drug0 t= tf -lrb- tcf0l0 -rrb- , drug0 t=tf -lrb- tcf0l0 -rrb- , drug0 -lrb- 0g/a , gck -rrb- , drug0 -lrb- e0k , kcnj0 -rrb- , drug0 -lrb- cdkal0 -rrb- , drug0 -lrb- igf0bp0 -rrb- , drug0 -lrb- mtnr0b -rrb- , drug0 -lrb- mtnr0b -rrb- and drug0 -lrb- gly0arg , irs0 -rrb- be significantly associate with a high risk of drug0 . 
among them , genetic variant in drug0 show the strong association with drug0 risk , with or -lrb- 0 % cis -rrb- of 0 -lrb- 0 , p < 0 -rrb- per t allele of drug0 and 0 -lrb- 0 , p = 0 -rrb- per t allele of drug0 
background : #crd# single-nucleotide polymorphism , drug0 and drug0 , located within the nicotinic acetylcholine receptor gene cluster on chromosome 0q0 locus , be associate with heaviness of drug0 , risk for drug0 , and other smoking-related health outcome . 
objective : we aim to replicate the association of the drug0 -lrb- ivs0c/t -rrb- and drug0 -lrb- ivs0c/t -rrb- polymorphism of transcription factor 0-like 0 -lrb- tcf0l0 -rrb- and drug0 -lrb- drug0 -rrb- in han chinese people in henan province , china . 
conclusion : the cc genotype and the recessive model of the variant drug0 -lrb- ivs0c/t -rrb- and cc haplotype of drug0 -lrb- ivs0c/t -rrb- and drug0 -lrb- ivs0c/t -rrb- in tcf0l0may be associate with drug0 in han chinese people in henan province , china . . 
here , we report replication of association between drug0 and #crd# snp in the case-control -lrb- drug0 , p=0 ; drug0 , p=0 ; and. drug0 , p=0 -rrb- and #crd# snp in the family-based -lrb- drug0 , p=0 and drug0 , p=0 -rrb- sample from northern sweden . 
this 0 indel -lrb- drug0 -rrb- be </modmar>reported</modmar> to be in strong linkage disequilibrium -lrb- ld -rrb- with a single nucleotide polymorphism -lrb- snp -rrb- 0 kilobases upstream of hla-c -lrb- 0t/c ; rs0 -rrb- in caucasian individual , make this snp a potential marker for both hla-c expression and drug0 disease progression 
#crd# polymorphism affect hla-csurface expression -lrb- drug0 and drug0 -rrb- have recently be identify , and show to influence progression of drug0 infection . 
objective : heterozygosity for a 0 base pair deletion in the ccr0 gene -lrb- ccr0wt/d0 -rrb- and the minor allele of a single-nucleotide polymorphism in the hcp0 gene -lrb- drug0 -rrb- and in the hla-c gene region -lrb- 0hla-c ; drug0 -rrb- have be associate with a drug0 
a single nucleotide polymorphism -lrb- snp -rrb- 0 kb upstream of hla-c -lrb- drug0 ; term 0 -rrb- associate with control of drug0 , and with level of hla-c messenger rna transcript and cell-surface expression , but the mechanism underlie its varied expression be unknown . 
result : significant association between the minor allele variant of snp hla-c drug0 and hcp0 drug0 and a low viral load at set point could be replicate in the drug0 . 
in adiposity-matched , normal-weight human , we show that subject homozygous for the fto drug0 drug0 a allele have dysregulated circulating level of the orexigenic hormone acyl-ghrelin and attenuate drug0 . 
through an exhaustive search of pair-wise interaction and a select search of three- to five-way interaction condition on significant pair-wise result , we identify 0 core snp in #crd# gene -lrb- fto : drug0 , drug0 , drug0 , drug0 , drug0 , drug0 ; tspan0 : drug0 ; tcf0l0 : drug0 , drug0 , drug0 , drug0 , drug0 , drug0 , drug0 , drug0 ; l0mbtl0 : drug0 , drug0 ; celf0 : drug0 , drug0 ; runx0 : drug0 , drug0 , drug0 , drug0 , drug0 -rrb- that appear to be important for drug0 . 
the increase in cotinine level indicate an increase risk of drug0 with each additional copy of the drug0 - drug0 risk allele 
objective : we investigate if the fto drug0 associate with food preference in healthy adult with no drug0 , drug0 disease , or drug0 . 
conclusion : the present study demonstrate that fto drug0 and combined snp be significantly associate with risk of drug0 , which seem to be dependent on bmi . 
conclusion : the present study demonstrate that fto drug0 and combined snp be significantly associate with risk of drug0 , which seem to be dependent on bmi . 
method : all drug0 patient be genotypedfor the fto single nucleotide polimorphysm -lrb- snp -rrb- drug0 . 
we investigate the drug0 single nucleotide polymorphism in the nicotine acetylcholine receptor gene cluster -lrb- chrna0-chrna0-chrnb0 -rrb- , associate with smoking phenotype , to determine whether woman who continue to smoke be also more likely to report a drug0 during pregnancy . 
we find among woman who smoke pre-pregnancy , those with the drug0 t allele smoke more and be less likely to quit drug0 during pregnancy , but be also less likely to report high level of drug0 at 0 week of pregnancy -lrb- per allele or = 0 , 0 % ci 0 to 0 , p = 0 -rrb- . 
the drug0 genetic variant within the chrna0-a0-b0 gene cluster be associate with drug0 and have recently be report to be associate with likelihood of drug0 . 
we investigate the potential association of drug0 glllenotype with reduce likelihood of drug0 in 0 cohort of treatment-seeking smoker in primary care in the united kingdom . 
there be evidence of association of drug0 genotype with drug0 in our open-label trial sample but not our placebo-controlled trial sample . 
moreover , the drug0 variant may not merely operate as a marker for drug0 . 
nominally significant association with candidatesnps within cholinergic receptor , nicotinic , alpha 0 -lrb- chrna0/chrna0 ; eg , p=0 for snp drug0 -rrb- and cytochrome p0 , family 0 , subfamily a , polypeptide 0 -lrb- cyp0a0 ; eg , p=0 * 0 -lrb- 0 -rrb- for a non-synonymous snp drug0 -rrb- region be observe for drug0 , however only cyp0a0 show evidence of significant association with drug0 . 
a candidate snp drug0 in drug0 be significantly -lrb- p=0 -rrb- associate with drug0 . 
we examine the association between the nicotinic acetylcholine receptor polymorphism drug0 on chromosome 0q0 mark thegene cluster chrna0-chrnb0-chrna0 , drug0 , and drug0 and drug0 in the general population . 
both the t-allele of drug0 and the t-allele of drug0 significantly increase drug0 risk with an allelic odds ratio -lrb- or -rrb- of 0 -lrb- 0 % ci 0 -rrb- -lrb- p = 0 x 0 -lrb- 0 -rrb- -rrb- and 0 -lrb- 0 -rrb- -lrb- p = 0 x 0 -lrb- 0 -rrb- -rrb- , respectively . 
the drug0 t at-risk allele associate with drug0 and early age at diagnosis in the drug0 subject -lrb- p = 0 x 0 -lrb- 0 -rrb- and p = 0 x 0 -lrb- 0 -rrb- , respectively -rrb- , which be supportedby quantitative family-based association test . 
we genotyped #crd# of the snp -lrb- drug0 , drug0 , drug0 , and drug0 -rrb- in amish subject with drug0 -lrb- n = 0 -rrb- , drug0 -lrb- igt ; n = 0 -rrb- , and drug0 -lrb- ngt ; n = 0 -rrb- . 
a-allele of drug0 be associate with an increase risk of drug0 regardless of smoking exposure -lrb- pooled or = 0 , 0 % ci 0 , p < 0⁻⁵ -rrb- . 
our finding suggest that drug0 in chrna be a susceptibility variant for drug0 , in term of both airway obstruction and parenchyma destruction . 
recently , a microsatellite marker in intron 0 drug0 and #crd# correlated single nucleotide polymorphism -lrb- snp -rrb- be identify in icelandic individual that show strong association with drug0 , which be replicate in danish and european-american cohort . 
we genotyped #crd# of the snp -lrb- drug0 , drug0 , drug0 , and drug0 -rrb- in amish subject with drug0 -lrb- n = 0 -rrb- , drug0 -lrb- igt ; n = 0 -rrb- , and drug0 -lrb- ngt ; n = 0 -rrb- . 
we compare genotype frequency in subject with drug0 with those with ngt and find marginal association for drug0 -lrb- p = 0 ; odds ratio -lsb-or -rsb- 0 -rrb- ; 
comparison between ngt control subject and the combined drug0 case group show strong association with drug0 and drug0 -lrb- p = 0 ; or 0 -rrb- and marginal association with drug0 and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- . 
we also genotyped these snp in nondiabetic , non-amish subject -lrb- n = 0 -rrb- , in whom intravenous drug0 test be performed , and find an association between drug0 and drug0 and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- and drug0 -lrb- p = 0 and p = 0 , respectively -rrb- . 
we examine the association of a common variant of the tcf0l0 gene -lrb- drug0 -rrb- with drug0 risk among caucasian . 
over an average period of #crd# year , participant with the risk-conferring tt genotype at drug0 be more likely to have progression from drug0 to drug0 than be cc homozygote -lrb- hazard ratio , 0 ; 0 percent confidence interval , 0 to 0 ; p<0 -rrb- . 
common variant in drug0 seem to be associate with an increase risk of drug0 among person with drug0 . 
the snp drug0 be nominally associate with drug0 in the initial -lrb- p = 0 -rrb- and #crd# replication sample set -lrb- p = 0 and 0 -rrb- . 
for the combined sample set , in which we successfully genotyped 0 type 0 diabetes patient and 0 control subject , drug0 show a significant association with drug0 -lrb- odds ratio = 0 -lsb-0 % ci 0 -rsb- , p = 0 -rrb- with the same direction as the previous report in sample from european and european-origin population . 
the rest of the #crd# snp -lrb- drug0 , drug0 and drug0 -rrb- do not show any significant association with drug0 . 
the consistent association between drug0 in tcf0l0 and drug0 in different ethnic group , include the japanese population , suggest that tcf0l0 be a common susceptibility gene for type 0 diabetes . 
the minor allele of drug0 -lrb- tcf0l0 -rrb- , drug0 -lrb- tcf0l0 -rrb- , drug0 -lrb- 0g/a , gck -rrb- , drug0 -lrb- e0k , kcnj0 -rrb- , drug0 -lrb- cdkal0 -rrb- , drug0 -lrb- igf0bp0 -rrb- , drug0 -lrb- mtnr0b -rrb- , drug0 -lrb- mtnr0b -rrb- and drug0 -lrb- gly0arg , irs0 -rrb- be significantly associate with a high risk of drug0 . 
in summary , by pool all available qualify datum from genetic study on drug0 and drug0 , we have confirm that drug0 be significantly associate with susceptibility to drug0 in the global population . 
in recent year , it have be widely accept that transcription factor 0-like 0 -lrb- tcf0l0 -rrb- be associate with type 0 diabetes mellitus drug0 in multiple ethnic group , especially its single nucleotide polymorphism of drug0 , drug0 and rs0t/c . 
in conclusion , this study indicate that the drug0 polymorphism of the tcf0l0 gene have a significant effect on drug0 risk in chinese han population , with drug0 and drug0 polymorphism show no significant effect . 
subgroup analysis show that significant association be not find between the #crd# snp -lrb- drug0 , drug0 , drug0 , drug0 , drug0 , and drug0 -rrb- and the drug0 in some ethnic population . 
the #crd# test tcf0l0 variant be in linkage disequilibrium , and 0-locus -lrb- drug0 , drug0 , drug0 , drug0 -rrb- haplotype analysis demonstrate that haplotype 0 be negatively associate -lrb- pc<0 -rrb- , while haplotype 0 -lrb- pc=0 -rrb- and 0 -lrb- pc=0 -rrb- be positively associate with drug0 risk , after control for a number of covariate . 
we evaluate the publish evidence for association between drug0 -lrb- k = 0 sample -rrb- and drug0 -lrb- k = 0 sample -rrb- snp with drug0 use meta-analytic technique . 
meta-analysis indicate compelling evidence of an association between the drug0 variant and drug0 -lrb- fixed effect : b = 0 , 0 % ci = 0 , 0 , p < 0 ; random effect : b = 0 , 0 % ci = 0 , 0 , p < 0 -rrb- , equivalent to a per-allele effect of approximately 0 cigarette/day . 
among woman with a history of drug0 , the tt genotype of drug0 increase drug0 risk -lrb- or , 0 ; 0 % ci 0 -rrb- 
conclusion : donor tcf0l0 drug0 polymorphism be associate with an increase risk of drug0 after lt and have a potential clinical value for the prediction of nodm . 
the minor t allele of tcf0l0 drug0 be find to significantly increase the risk of drug0 , with an allelic odds ratio -lrb- or -rrb- of 0 -lrb- 0 % ci 0 , p = 0 -rrb- . 
we also find a strong correlation between the drug0 and the presence of drug0 -lrb- p = 0 with a high or = 0 -rrb- . 
we conclude that drug0 gtcf0l0 variant be associate with peripheral drug0 in drug0 but this effect be not see in control woman . 
conclusion : tcf0l0 drug0 polymorphism protect mexican child from drug0 . 
thada variant -lrb- drug0 -rrb- be associate with drug0 -lrb- or 0 ; 0 % ci 0 , 0 ; p = 0 -rrb- . 
if the application of tcf0l0 drug0 snp as a marker for drug0 be confirm by far independent study , replace tacrolimus with other immunosuppressant could be warrant in patient at high risk of drug0 , as diagnose by tcf0l0 genotyping . 
in addition , an association of #crd# snp of the tcf0l0 gene with drug0 be observe in both city : drug0 , -lrb- for guerrero or = 0 ci0 % 0 and for mexico or = 0 ci0 % 0 -rrb- and drug0 -lrb- or = 0 ci0 % 0 , or = 0 ci0 % 0 respectively -rrb- . 
no interaction be observe between drug0 and hla-dqb0 * 0 , which be show to be negatively associate with drug0 in mother bear in sweden -lrb- p = 0 -rrb- . 
a genetic variant within the chrna0-chrna0-chrnb0 region -lrb- drug0 -rrb- , previously associate with drug0 quantity , be recently show to interact with drug0 on drug0 predisposition . 
the drug0 variant be not significantly associate with drug0 status or snus use -lrb- p > 0 -rrb- ; the t allele be associate with low bmi in the overall cohort -lrb- b = 0 kg/m -lrb- 0 -rrb- , se = 0 ; p = 0 -rrb- and with drug0 quantity in those in whom this be measure -lrb- n = 0 -rrb- -lrb- b = 0 , se = 0 ; p < 0 -rrb- 
the drug0 -lrb- t -rrb- allele genotype be significantly associate with drug0 -lrb- p = 0 -rrb- but drug0 -lrb- t -rrb- allele genotype be not associate with the clinico-pathologic characteristic . 
thus , we have show that the drug0 and drug0 marker be independent genetic drug0 risk factor in a russian population . 
thus , we have show that the drug0 and drug0 marker be independent genetic drug0 risk factor in a russian population . 
the non-synonymous drug0 polymorphism of the adrb0 gene be associate with drug0 -lrb- trpallele , or = 0 , p = 0 -rrb- and drug0 -lrb- trp allele , or = 0 , p = 0 -rrb- . 
background : single nucleotide polymiorphisms -lrb- snp -rrb- drug0 and drug0 located within tcf0l0 gene have be identify as the strong common genetic risk factor for development of drug0 -lrb- t0d -rrb- . 
conclusion : although the biology of the wnt/beta-catenin signaling pathway and prior association between drug0 and numerous phenotype warrant examination of this tcf0l0 snp , no compelling evidence for association with breast or drug0 be observe . 
however , the risk allele at tcf0l0 drug0 be more frequent in drug0 subject than in control when we restrict the analysis to the subject with low weight-for-height than the median of the pa subject -lrb- 
to investigate the expression of drug0 protein in normal breast tissue , and examine the difference in abcc0 mrna and proteinexpression between normal breast and drug0 tissue take into account abcc0 genotype -lrb- a functional snp , drug0 -rrb- and estrogen receptor -lrb- er -rrb- status 
in the present study , to determine whether the snp can serve as a diagnostic marker for drug0 -lrb- ao -rrb- , we examine genotype at drug0 in 0 japanese ao individual . 
in europeans , #crd# haplotype in the region have be show to be associate with eye pigmentation and a missense snp -lrb- drug0 -rrb- have be associate with drug0 
our datum suggest that the haplotype restrict to europe be the strong marker for drug0 globally and add far inferential evidence that the derive allele of drug0 be an east asian drug0 allele . 
moreover , the tt genotype of the nicotinic acetylcholine receptor -lrb- nachr -rrb- a0-subunit -lrb- chrna0 -rrb- drug0 polymorphism have previously be associate with drug0 and drug0 . 
we find that the variant allele of oca0 r0q -lrb- drug0 -rrb- be associate with increase risk of drug0 -lrb- 
we be also able to demonstrate the oca0 r0q , drug0 , cod snp act as a penetrance modifier of this new drug0 snp for eye color , and somewhat independently , of drug0 risk . 
conclusion : genetic variation of drd0 , specifically the drug0 polymorphism , may produce an early clinical presentation of drug0 disease neuropsychiatric symptom and sign that occur in the course of dopaminergic system impairment due to copper accumulation in the brain . 
we investigate the relationship between drug0 symptom and dopamine receptor 0 drd0 gene polymorphisms-0 c i/d -lrb- drug0 -rrb- exon 0 g/a -lrb- drug0 -rrb- and ankk0 -lrb- ankyrin repeat and kinase domain containing 0 -rrb- gene polymorphism taq0a -lrb- drug0 -rrb- 
these result strongly suggest that a0+ variant of the drug0 allele do confer an associate risk for drug0 inpatient who be treat with sgas , and these variant may explain inconsistency find across prior study , when compare fgas and sgas . 
#crd# tag single nucleotide polymorphism -lrb- snp -rrb- in the prcp gene and #crd# tag snp and g-0a drug0 polymorphism in the cma0 gene be genotyped in the drug0 -lrb- n=0 -rrb- use a polymerase chain reaction-restriction fragment length polymorphism method 
conclusion : the present result indicate prcp drug0 can be consider as a marker for eh and hap0 gagcactaaca -lrb- prcp -rrb- and hap0 ttta -lrb- cma0 -rrb- might be associate with drug0 in chinese han population . 
previous study have indicate that cma0 promoter polymorphism drug0 may be involve in regulate immunoglobulin e -lrb- ige -rrb- level in patient with drug0 , and it be associate with the progression of drug0 . 
polymorphism drug0 of cma0 may be associate with serum ige level in drug0 subject , but not with chymase level in both group . 
conclusion : our result suggest that the cma drug0 polymorphism be associate with the progression of drug0 inkorean patient . 
in the leuven cohort , drug0 aa-carriers and rs0 gg-carriers have a two-fold increase risk to suffer from drug0 gold iv -lrb- 
conclusion : result confirm previous observation of a significant association between the cma0 promoter polymorphism drug0 and atopic drug0 , but not with serum ige level , and support the hypothesis that cma0 serve as candidate gene for atopic eczema . 
the increase risk of brain drug0 be evident for cyp0a0 drug0 -lrb- p = 0 ; or = 0 ; 0 % ci , 0 -rrb- and minor haplotype drug0 - drug0 - drug0 in female -lrb- global haplotypeassociation p value , 0 -rrb- . 
only stk0 drug0 be significantly associate with high dbp -lrb- p = 0 -rrb- in the drug0 subject . 
the association between drug0 and drug0 susceptibility have be widely study . 
conclusion : drug0 polymorphism of mthfr gene may increase the risk of drug0 cancer in the complete over-dominant model . 
the actn0 r0x -lrb- drug0 -rrb- polymorphism determine the presence or absence of functional actn0 , which may influence the extent of exercise-induced drug0 . 
we conclude that hif0a drug0 polymorphism by itself be not critical in determine drug0 . 
to good of our knowledge , we #ord# screen these variant know to be associate with drug0 disease , e0k -lrb- drug0 -rrb- in snca , drug0 in lrrk0 , drug0 n park0 , drug0 in slc0a0 , drug0 , drug0 , g0r -lrb- drug0 -rrb- , 0fs -lrb- drug0 -rrb- in nod0 and g0r -lrb- drug0 -rrb- in lrrk0 from southern china population . 
drug0 be positively associate with the risk allele of il0r drug0 -lrb- or = 0 -lsb-0 -rsb- -rrb- and 0q0 drug0 -lrb- or = 0 -lsb-0 -rsb- and negatively associate with the risk allele of irgm drug0 -lrb- or = 0 -lsb-0 -rsb- -rrb- and defb0 drug0 -lrb- or = 0 -lsb-0 -rsb- -rrb- . 
in genotype-association snp analysis , all nod0 snp -lrb- drug0 , drug0 , drug0 -rrb- and the il0r snp -lrb- drug0 -rrb- show a significant association to drug0 -lrb- p < 0 -rrb- . 
#crd# nod0/card0 variant , namely #crd# missense polymorphism drug0 and drug0 , and a frame shift polymorphism drug0 , be associate with drug0 in caucasian population . 
our analysis reveal that effect of #crd# linked variant -lrb- drug0 and drug0 -rrb- in the agphd0/chrna0 cluster on drug0 development be significantly , yet not entirely , mediate by the smoking-related phenotype 
in association analysis , we find statistically significant association of drug0 -lrb- p 0 , or=0 , ci0 % 0 -rrb- and drug0 -lrb- p=0 * 0<formula>^ -lcb- 0 -rcb- </formula> , or=0 , ci0 % = 0 -rrb- polymorphism with drug0 patient . 
whereas the nod0 genotype and drug0 be positively associate with drug0 , the drug0 genotype be positively associate with drug0 -lrb- l0 -rrb- disease . 
the association between the serine/threonine kinase 0 -lrb- stk0 -rrb- f0i polymorphism -lrb- drug0 -rrb- and drug0 susceptibility remain controversial . 
stratified analysis by drug0 type reveal that the stk drug0 polymorphism may contribute to the risk of drug0 -lrb- aa vs. tt : or=0 , 0 % ci=0 , pheterogeneity=0 -rrb- , drug0 -lrb- aa vs. unassigned : or=0 , 0 % ci=0 , pheterogeneity=0 -rrb- , and drug0 -lrb- aa vs. unassigned : or=0 , 0 % ci=0 , pheterogeneity=0 -rrb- 
the result show that #crd# snp in aurka -lrb- datum in recessive model , drug0 : or = 0 , 0 % ci = 0 , p = 0 ; drug0 : or = 0 , 0 % ci = 0 , p = 0 ; drug0 : or = 0 , 0 % ci = 0 , p = 0 ; drug0 : or = 0 , 0 % ci = 0 , p = 0 -rrb- and #crd# snp in brca0 -lrb- drug0 , dominant model or = 0 , 0 % ci = 0 , p = 0 -rrb- be associate with drug0 susceptibility . 
method : #crd# single nucleotide polymorphism -lrb- snp -rrb- in the aurka -lrb- drug0 -rrb- , erbb0 -lrb- drug0 -rrb- , mdm0 -lrb- drug0 -rrb- , cdh0 -lrb- drug0 -rrb- , cdkn0a -lrb- drug0 -rrb- , and tp0 -lrb- drug0 -rrb- gene be genotyped in a consecutive cohort of 0 drug0 patient , who have undergo surgical resection with curative intent . 
however , in a multivariate analysis , patient with drug0 carry the heterozygous mdm0 -lrb- drug0 -rrb- t/g genotype have significantly improve dfs compare with patient carry the wild-type genotype -lrb- adjust hazard ratio -lrb- ahr -rrb- , 0 ; 0 % confidence interval -lrb- ci -rrb- -lsb-0 -rsb- -rrb- . 
in addition , high frequency of the mmp0 drug0 0g allele -lrb- p = 0 , or 0 , 0 % ci 0 -rrb- and the mmp0/mmp0 drug0 / drug0 0g/g haplotype -lrb- or 0 , 0 % ci 0 -rrb- be detect in drug0 patient than in control -lrb- n = 0 -rrb- . 
the presence of the variant allele tnfa c.-0a -lrb- drug0 -rrb- be associate with low serum level of tnf-a , and with significantly decrease risk of drug0 in both cohort . 
background : evidence have suggest that tumour necrosis factor -lrb- tnf -rrb- -a may be involve in the aetiology of psoriasis , but the underlying association of the tnf-a polymorphism 0g/a -lrb- drug0 -rrb- and 0g/a -lrb- drug0 -rrb- with the risk of drug0 be still unconfirmed . 
result : risk allele previously associate with drug0 be significantly -lrb- p<0 -rrb- associate with reduce abstinence in the pla pharmacotherapy group -lrb- pg -rrb- at 0mo -lsb-for drug0 , odds ratio -lrb- 0 % confidence interval -rrb- 0 -lrb- 0 -rrb- -rsb- , and at end of treatment and at 0mo -lsb-for drug0 , 0 -lrb- 0 -rrb- and 0 -lrb- 0 -rrb- -rsb- , and with increase abstinence in the nrt pg at 0mo -lsb-for drug0 , 0 -lrb- 0 -rrb- and for drug0 , 0 -lrb- 0 -rrb- -rsb- 
conclusion : this meta-analysis suggest that the drug0 and 0 promoter polymorphism may play different role in confer susceptibility to drug0 . 
we genotyped and analyze 0 snp in 0 gene : ptpn0 c0t -lrb- drug0 -rrb- , tnfa g-0a , g-0a -lrb- drug0 , drug0 -rrb- and mif g-0c -lrb- drug0 -rrb- in 0 drug0 case and 0 healthy control . 
conclusion : we have confirm association between drug0 and drug0 and drug0 . 
conclusion : the drug0 be find to be predictive of clinical response and be more likely to predict long-term survival in japanese drug0 patient receive definitive 0-fu/cddp-based crt . 
result : drug0 compare to healthy individual demonstrate a statistically significant increase in drug0 allele -lrb- p = 0 , or = 0 , 0 % ci 0 -rrb- . 
result : genome-wide significance in fully adjust model -lrb- sex , age , apoe genotype , population stratification -rrb- be observe for a snp in drug0 -lrb- drug0 , allele = g ; frequency , 0 case and 0 control ; odds ratio -lsb-or -rsb- , 0 -lsb-0 % ci , 0 -rsb- ; p = 0 * 0 -lrb- 0 -rrb- -rrb- , which be in linkage disequilibrium with snp previously associate with drug0 disease in europeans -lrb- 0 < d' < 0 -rrb- . 
genotyping be performed for #crd# single-nucleotide polymorphism that have be associate with drug0 : drug0 , drug0 , drug0 , drug0 , and clstn0 -lrb- drug0 -rrb- . 
#crd# snps-lsb- drug0 in apoe : odds ratio -lrb- or -rrb- 0 , 0 % confidence interval -lrb- ci -rrb- 0 , p=0 * 0 ; drug0 in apoe : or=0 , 0 % ci=0 , p=0 * 0 ; and drug0 in picalm : or=0 , 0 % ci=0 , p=0 , log additive model -rsb- be significantly associate with drug0 susceptibility after correction for multiple testing . 
background : single nucleotide polymorphism -lrb- snp -rrb- drug0 -lrb- e0 -rrb- and drug0 -lrb- e0 -rrb- , both invoke change in the amino-acid sequence of the apolipoprotein e -lrb- apoe -rrb- gene , have previously be test for association with drug0 -lrb- ms -rrb- risk . 
result : despite sufficient power to detect association at genome-wide significance threshold across a range of or , our analysis do not support a role of drug0 or drug0 on drug0 susceptibility 
the distribution of snp relate to the amyloid cascade hypothesis -lrb- tomm0 drug0 g and tomm0 drug0 g -rrb- , to the drug0 -lrb- apoe drug0 c , ldlr drug0 g and ch0h drug0 t and plau drug0 ct -rrb- and to the tau hypothesis -lrb- mapt/sth drug0 gg -rrb- in amci be significantly different than those in normal control . 
the author then performed a large meta-analysis of 0 study examine the association of drug0 with polymorphism in the tcf0l0 gene in various ethnicity , contain drug0 c-to-t -lrb- ivs0c>t -rrb- , drug0 t-to-c -lrb- ivs0t>c -rrb- , a drug0 g-to-t -lrb- ivs0g>t -rrb- , and drug0 g-to-c -lrb- ivs0g>c -rrb- polymorphism and toevaluate the size of gene effect and the possible genetic mode of action 
carbohydrate quality and quantity modify risk of drug0 associate with drug0 , which suggest that change in risk attributable to the tcf0l0 variant be magnify under condition of increase insulin demand . 
we genotyped the tcf0l0 single nucleotide polymorphism drug0 and drug0 -lrb- previously associate with drug0 -rrb- and drug0 nd drug0 -lrb- which tag haplotype a -lsb-hapa -rsb- , a haplotype report to be associate with drug0 -rrb- in 0 fhs participant . 
as expect , the t risk allele of drug0 be associate with high drug0 -lrb- p = 0 -rrb- . 
there be no association of drug0 with drug0 -lrb- p = 0 -rrb- , drug0 -lrb- p = 0 -rrb- , drug0 -lrb- p = 0 -rrb- or drug0 -lrb- p = 0 -rrb- . 
we confirm that the risk allele of drug0 be associate with drug0 and a drug0 . 
we do not detect any association of the drug0 with drug0 , 
we investigate the effect of single nucleotide polymorphism -lrb- snp -rrb- , drug0 and drug0 , within the tcf0l0 locus on drug0 and other drug0 and their modulation by dietary fat . 
in summary , drug0 -lrb- > or = 0 % of energy intake -rrb- be associate with drug0 in carrier of the minor t allele at the tcf0l0 drug0 snp and may predispose them to met , diabetes , and cardiovascular disease . 
we find that snp drug0 , drug0 , drug0 and drug0 in the tcf0l0 gene be strongly associate with drug0 -lrb- p<0 -rrb- . 
in drug0 , t0d patient carry genotype ct or tt have drug0 -lrb- fpg -rrb- level -lrb- p=0 -rrb- and drug0 -lrb- p=0 -rrb- and drug0 -lrb- p=0 -rrb- compare to the patient carry cc genotype . 
furthermore , the risk allele from tcf0l0 drug0 polymorphism either with drug0 polymorphism -lrb- p=0 , or=0 -rrb- or with drug0 polymorphism -lrb- p=0 , or=0 -rrb- be significantly associate with drug0 . 
the allele and genotype frequency of #crd# snp drug0 and drug0 show that these be associate -lrb- odds ratio up to 0 -rrb- with the development of drug0 in the autoantibody-negative diabetic cohort , but not in the autoantibody-positive diabetic cohort . 
in our case-control subject , susceptibility to drug0 be replicate in tcf0l0 drug0 , cdkal0 drug0 , drug0 , hhex -lrb- drug0 -rrb- , igf0bp0 -lrb- drug0 and drug0 -rrb- , cdkn0a/b -lrb- drug0 -rrb- , and slc0a0 -lrb- drug0 -rrb- . 
in addition to these polymorphism , meta-analysis confirm the association of drug0 susceptibility with kcnj0 drug0 , tcf0l0 drug0 , and hhex drug0 . 
the tcf0l0 drug0 polymorphism show the high odds ratio -lrb- or -rrb- for drug0 -lrb- or 0 -lsb-0 -rsb- -rrb- . 
odds ratio of other polymorphism range from 0 to 0. the risk allele of cdkal0 drug0 be significantly associate with drug0 patient after adjustment for other confound factor . 
compare with control -lrb- man and woman combine -rrb- , drug0 be associate with drug0 and drug0 -lrb- or 0 , 0 % ci 0 , p = 0 x 0 -lrb- 0 -rrb- -rrb- in cdkal0 ; drug0 -lrb- or 0 , 0 % ci 0 , p = 0 x 0 -lrb- 0 -rrb- -rrb- in the cdkn0a-cdkn0b region ; drug0 -lrb- or 0 , 0 % ci 0 , p = 0 -rrb- , drug0 , and drug0 in hhex ; drug0 -lrb- or 0 , 0 % ci 0 , p = 0 -rrb- in igf0bp0 ; drug0 -lrb- or 0 , 0 % ci 0 , p = 0 -rrb- in slc0a0 ; and drug0 -lrb- or 0 , 0 % ci 0 , p = 0 -rrb- in tcf0l0 . 
the risk allele of the snp drug0 and drug0 in cdkal0 ; drug0 in the cdkn0a-cdkn0b region ; and drug0 , drug0 and drug0 in hhex be associate with drug0 auc during a 0 g ogtt performed at the time of diagnosis of drug0 . 
the risk allele of the tcf0l0 gene -lrb- drug0 and drug0 -rrb- be strongly associate with drug0 , even after control for traditional risk factor in both a cross-sectional and prospective setting . 
the minor allele frequency of drug0 , drug0 and drug0 be significantly high in drug0 patient compare with that in non-diabetic individual . 
the t -lrb- minor -rrb- allele of the variant drug0 be significantly associate with a great or for drug0 adjust for age , sex and bmi in logistic regression analysis : 
no statistically significant association of the snp be observe with drug0 or drug0 or between carrier and non-carriers of drug0 and drug0 mutation . 
while , drug0 show a statistically significant association between drug0 and drug0 patient carry the 0v allele -lrb- or = 0 , 0 % ci = 0 , p = 0 -rrb- . 
the drug0 and drug0 variant of tcf0l0 have be strongly associate with drug0 risk in most population study to date . 
comparison between allele and genotype frequency of these snp in patient and control show marginal association for drug0 and drug0 with drug0 -lrb- p = 0 , or 0 , 0 % ci 0 ; p = 0 , or 0 , 0 % ci 0 , respectively -rrb- . 
no association be find for drug0 , drug0 , c.0c>a and drug0 -lrb- p = 0 -rrb- . 
we evaluate the association of a polymorphism in tcf0l0 drug0 in the wnt signaling pathway , which previously have be strongly associate with risk of drug0 , with drug0 and drug0 in the prospective nurses ' health study -lrb- nhs -rrb- and health professionalsfollow-up study -lrb- hpfs -rrb- cohort . 
overall , in the nhs and hpfs , there be suggestive evidence for an inverse association associate with homozygosity for the minor allele of drug0 and drug0 -lrb- conditional and covariate adjust or = 0 , 0 % ci : 0 ; p for heterogeneity 0 for the association in woman and man -rrb- . 
this result suggest that the increase drug0 associate with drug0 genotype be specific to drug0 . 
specifically , the same risk allele of single nucleotide polymorphism -lrb- snp -rrb- drug0 that be associate with drug0 -lrb- t allele -rrb- have recently be associate with an increase risk of drug0 . 
the minor allele of each variant be significantly associate with drug0 ; the great risk of develop the disease be confer by drug0 , with an allelic odds ratio -lrb- or -rrb- of 0 -lrb- 0 % ci : 0 - 0 , p = 0 x 0 -lrb- 0 -rrb- -rrb- . 
drug0 disease stage be marginally significantly associate with the frequency of the t variant at drug0 -lrb- p=0 ; adjust p=0 -rrb- but not at drug0 -lrb- p=0 ; adjust p=0 -rrb- . 
comparison between subject with drug0 and the combined drug0 show a significant association with drug0 -lrb- or 0 , ci 0 ; p=0 -rrb- but not with drug0 -lrb- or 0 , ci 0 ; p=0 -rrb- . 
these datum suggest that drug0 be associate with increase risk for drug0 in emirati subject . 
the minor allele of drug0 , drug0 , and drug0 show significant association with drug0 -lrb- or=0 , p=0 x 0 -lrb- 0 -rrb- ; or=0 , p=0 x 0 -lrb- 0 -rrb- ; or=0 , p=0 x 0 -lrb- 0 -rrb- , respectively -rrb- in the combined sample set , however , neither drug0 nor drug0 show a significant association . 
significant evidence for association be observe for high tg for the t allele of drug0 and drug0 -lrb- p = 0 and p = 0 -rrb- in mexican drug0 family , no evidence for association be observe for drug0 , drug0 , drug0 in mexicans . 
when test drug0 and drug0 for replication in finnish drug0 family , these single nucleotide polymorphism be associate with drug0 -lrb- p = 0 and p = 0 -rrb- . 
these datum show that drug0 and drug0 be significantly associate with high drug0 in drug0 family from #crd# different population . 
these datum suggest that the tcf0l0 drug0 genetic variation be associate with an increase risk of drug0 . 
#crd# representative variant , drug0 , be nominally associate with drug0 in a general model -lrb- additive p = 0 , dominant p = 0 -rrb- but not in a within-family analysis -lrb- additive p = 0 , dominant p = 0 -rrb- . 
however , several variant be associate with drug0 ; in particular , drug0 be associate in both general and within-family analysis -lrb- both p = 0 -rrb- . 
there be no association between drug0 and drug0 in the uk case-control study -lrb- cochran-armitage test , p = 0 -rrb- ; nor with symptomatic status in the finnish cohort -lrb- p = 0 -rrb- . 
in addition , there be no relationship between the tcf0l0 single nucleotide polymorphism drug0 and drug0 -lrb- uk case , p = 0 ; finnish control , p = 0 ; finnish symptomatic case , p = 0 -rrb- . 
the frequency of the t allele of both drug0 and drug0 polymorphism be significantly high in drug0 subject -lrb- 0 % and 0 % -rrb- compare to that in normal glucose-tolerant subject -lrb- 0 % and 0 % ; p = 0 and p = 0 , respectively -rrb- . 
normal glucose-tolerant subject with the tt genotype of drug0 have significantly high drug0 -lrb- mean +/- sd , 0 +/- 0 mmol/l -rrb- than those with the gg genotype -lrb- 0 +/- 0 mmol/l , p = 0 -rrb- . 
normal glucose-tolerant subject with the tt genotype of drug0 polymorphism have significantly high drug0 -lrb- mean +/- sd , 0 +/- 0 mmol/l -rrb- than those with the cc genotype -lrb- 0 +/- 0 mmol/l , p = 0 -rrb- . 
in conclusion , the t allele of the drug0 and drug0 polymorphism of tcf0l0 gene confer susceptibility to drug0 in asian indians . 
the ct/tt genotype of snp drug0 strongly predict future drug0 in 0 independent cohort -lrb- swedish and finnish -rrb- . 
these result extend previous observation to other ethnic group , and strongly confirm that drug0 genotype be a major risk factor for development of drug0 . 
however , glp-0-infusion combine with a hyperglycaemic clamp show a significant reduction in drug0 in carrier of the risk allele in #crd# variant -lrb- drug0 drug0 p < 0 -rrb- , 
we analyse #crd# single nucleotide polymorphism -lrb- snp -rrb- , drug0 and drug0 , in the transcription factor 0-like 0 gene -lrb- tcf0l0 -rrb- , which be associate with an increase risk of drug0 . 
both tcf0l0 snp -lrb- drug0 and drug0 -rrb- be find to be significantly associate with drug0 when adjust for insulin sensitivity , both in the whole cohort and when the diabetic subject be exclude . 
the most significant association be observe with tcf0l0 intron 0 snps drug0 -lrb- additive p = 0 x 0 -lrb- 0 -rrb- , odds ratio -lsb-or -rsb- 0 ; admixture-adjusted p -lrb- a -rrb- = 0 x 0 -lrb- 0 -rrb- -rrb- and drug0 -lrb- p = 0 , or 0 ; p -lrb- a -rrb- = 0 -rrb- , the 0-snp haplotype contain these snp be also associate with drug0 -lrb- p = 0 x 0 -lrb- 0 -rrb- -rrb- 
the previously report snp drug0 and drug0 of the tcf0l0 gene be rare and be not associate with drug0 in a chinese population , which may attribute to the low frequency of these #crd# snp . 
snp drug0 located in an ld block close to the 0 ' end of the gene be associate with drug0 -lrb- allele-specific p = 0 ; permuted p = 0 -rrb- . 
we study the effect of tcf0l0 drug0 and drug0 genotype on drug0 
we observe a significant association between the single-nucleotide polymorphism -lrb- snp -rrb- drug0 and the microsatellite drug0 with drug0 in the mexican sample 
the snp drug0 show similar trend , but its association with drug0 be not as strong -lrb- or = 0 , p = 0 -rrb- . 
in the dps , the tt genotype of drug0 be significantly associate with an adjust 0-fold risk -lrb- 0 % ci 0 , p = 0 -rrb- of incident drug0 in the control group , but not in the intervention group . 
the t allele of drug0 be significantly associate with decrease drug0 -lrb- study ii , iii -rrb- . 
the variant of drug0 of tcf0l0 be associate with incident drug0 in the dps and in a separate population-based cross-sectional study . 
we genotyped 0 participant for drug0 and drug0 and analyse the role in drug0 susceptibility use binary logistic regression. age , sex and obesity status be examine as covariate 
result : all investigate polymorphism be significantly associate with drug0 , and drug0 show the strong association -lrb- t vs g , chi0 = 0 , p = 0 , odds ratio = 0 , 0 % ci = 0 -rrb- , 
however , drug0 show association with 0 ' deltainsulin -lrb- drug0 -rrb- in an interaction with percentage of body fat -lrb- bonferroni-corrected p = 0 -rrb- . 
drug0 also show an association with beta-cell compensation for drug0 base on 0 ' deltainsulin in an interaction with percentage of body fat -lrb- bonferroni-corrected p = 0 -rrb- . 
drug0 be also associate with drug0 -lrb- odds ratio -lsb-or -rsb- 0 -lsb-0 % ci 0 -rsb- ; p = 0 -rrb- in our case-control sample . 
we observe nominal association between #crd# snp -lrb- drug0 , drug0 , drug0 , and drug0 -rrb- in #crd# haplotype block and drug0 , age at diagnosis , and 0-h glucose level -lrb- p = 0 -rrb- . 
